MetaCap

Century Therapeutics Inc. Company Profile

NASDAQ: IPSCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.17-0.155 (-11.74%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Century Therapeutics at a glance

Century Therapeutics Inc. (NASDAQ: IPSC) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Philadelphia, PA. Century Therapeutics is led by Dr. Brent Pfeiffenberger M.B.A., Pharm.D. and employs about 78 people. The company's shares have traded publicly since 2021.

At a market capitalization of $211.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001850119, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Century Therapeutics do?

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Business description based on the company's public filings.

Company information

Legal name
Century Therapeutics Inc.
Ticker
NASDAQ: IPSC
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Brent Pfeiffenberger M.B.A., Pharm.D.
Employees
78
Headquarters
25 North 38th Street, Philadelphia, PA, United States
Phone
267 817 5790
IPO year
2021
Market cap
$211.56M
SEC CIK
0001850119
Latest annual report
10-K · Mar 12, 2026

Companies similar to Century Therapeutics

IPSC peer companies
CompanyPrice% ChgMarket capCompare
ALLOAllogene Therapeutics Inc.0.6277-5.88%$217.48Mvs IPSC
CABACabaletta Bio Inc.0.9361-7.32%$201.94Mvs IPSC
LCTXLineage Cell Therapeutics Inc.0.7719-5.87%$195.26Mvs IPSC
SCTXScribe Therapeutics Inc.12.07-8.70%$228.58Mvs IPSC
ARTVArtiva Biotherapeutics Inc.3.78-1.31%$186.85Mvs IPSC
IKTInhibikase Therapeutics Inc.1.32+1.54%$185.16Mvs IPSC
AUTLAutolus Therapeutics plc ADR0.9073-7.38%$241.65Mvs IPSC
PLXProtalix BioTherapeutics Inc. (DE)2.90-5.23%$244.52Mvs IPSC

Related